Dr. Christian Barbato, MD, received his Ph.D. in “Neuroscience” in 2001 from Tor Vergata University of Rome. From 2005 to 2009,
he was an Associate Researcher at the Fondazione EBRI Rita Levi-Montalcini,
European Brain Research Institute, MicroRNAs in the Nervous System Unit, Rome,
Italy. Since 2009, he has been appointed as a Full Researcher at the Institute
of Cell Biology and Neurobiology (IBCN), National Research Council (CNR). His
main research fields focus on the function of microRNAs and their gene targets
implicated in physiological and pathological (neurodegenerative diseases,
Alzheimer’s disease) processes of neurons. His more recent work aims at the characterization
of cellular and molecular neurobiology of RISC (RNA-induced silencing complex)
and non-coding RNA, translational neurobiology and biomedicine of post-COVID-19
syndrome.
Dr. Christian Barbato, MD, received his Ph.D. in “Neuroscience” in 2001 from Tor Vergata University of Rome. From 2005 to 2009,
he was an Associate Researcher at the Fondazione EBRI Rita Levi-Montalcini,
European Brain Research Institute, MicroRNAs in the Nervous System Unit, Rome,
Italy. Since 2009, he has been appointed as a Full Researcher at the Institute
of Cell Biology and Neurobiology (IBCN), National Research Council (CNR). His
main research fields focus on the function of microRNAs and their gene targets
implicated in physiological and pathological (neurodegenerative diseases,
Alzheimer’s disease) processes of neurons. His more recent work aims at the characterization
of cellular and molecular neurobiology of RISC (RNA-induced silencing complex)
and non-coding RNA, translational neurobiology and biomedicine of post-COVID-19
syndrome.